Virtu Financial’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-11,126
| Closed | -$16K | – | 1678 |
|
2025
Q1 | $16K | Buy |
+11,126
| New | +$16K | ﹤0.01% | 1134 |
|
2023
Q4 | – | Sell |
-2,467
| Closed | -$18K | – | 1721 |
|
2023
Q3 | $18K | Buy |
+2,467
| New | +$18K | ﹤0.01% | 1030 |
|
2023
Q2 | – | Sell |
-176
| Closed | -$13K | – | 1699 |
|
2023
Q1 | $13K | Buy |
+176
| New | +$13K | ﹤0.01% | 1315 |
|
2022
Q4 | – | Sell |
-125
| Closed | -$7K | – | 1819 |
|
2022
Q3 | $7K | Buy |
+125
| New | +$7K | ﹤0.01% | 1550 |
|
2022
Q1 | – | Sell |
-200
| Closed | -$65K | – | 1686 |
|
2021
Q4 | $65K | Buy |
+200
| New | +$65K | 0.01% | 1265 |
|
2020
Q3 | – | Sell |
-83
| Closed | -$71K | – | 1238 |
|
2020
Q2 | $71K | Buy |
+83
| New | +$71K | 0.01% | 948 |
|
2018
Q3 | – | Sell |
-78
| Closed | -$166K | – | 1775 |
|
2018
Q2 | $166K | Buy |
+78
| New | +$166K | 0.01% | 1550 |
|